-
2
-
-
51349098242
-
IgA nephropathy: Challenges and opportunities
-
Glassock RJ. IgA nephropathy: challenges and opportunities. Cleve Clin J Med. 2008;75:569-76.
-
(2008)
Cleve Clin J Med
, vol.75
, pp. 569-576
-
-
Glassock, R.J.1
-
3
-
-
68949206247
-
The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility
-
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society
-
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546-56.
-
(2009)
Kidney Int
, vol.76
, pp. 546-556
-
-
Roberts, I.S.1
Cook, H.T.2
Troyanov, S.3
-
4
-
-
0347362489
-
Treatment of primary IgA nephrophty
-
Alexopoulos E. Treatment of primary IgA nephrophty. Kidney Int. 2004;64:341-56.
-
(2004)
Kidney Int
, vol.64
, pp. 341-356
-
-
Alexopoulos, E.1
-
5
-
-
0346734162
-
Corticosteroid Effectiveness in IgA Nephropathy: Long-Term Results of a Randomized, Controlled Trial
-
DOI 10.1097/01.ASN.0000103869.08096.4F
-
Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;5:157-63. (Pubitemid 38020707)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.1
, pp. 157-163
-
-
Pozzi, C.1
Andrulli, S.2
Del, V.L.3
Melis, P.4
Fogazzi, G.B.5
Altieri, P.6
Ponticelli, C.7
Locatelli, F.8
-
6
-
-
71049125647
-
Randomized controlled clinical trial of corticosteroids plus ACEinhibitors with long-term follow-up in proteinuric IgA nephropathy
-
Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACEinhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24:3694-701.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 3694-3701
-
-
Manno, C.1
Torres, D.D.2
Rossini, M.3
Pesce, F.4
Schena, F.P.5
-
7
-
-
0033978462
-
Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
-
Shoji T, Nakanishi I, Suzuki A, et al. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis. 2000;35:194-201. (Pubitemid 30070839)
-
(2000)
American Journal of Kidney Diseases
, vol.35
, Issue.2
, pp. 194-201
-
-
Shoji, T.1
Nakanishi, I.2
Suzuki, A.3
Hayashi, T.4
Togawa, M.5
Okada, N.6
Imai, E.7
Hori, M.8
Tsubakihara, Y.9
-
8
-
-
0036139035
-
Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy
-
Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002;13:142-8. (Pubitemid 34042021)
-
(2002)
Journal of the American Society of Nephrology
, vol.13
, Issue.1
, pp. 142-148
-
-
Ballardie, F.W.1
Roberts, I.S.D.2
-
9
-
-
74449086794
-
Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series
-
Bantis C, Stangou M, Schlaugat C, Alexopoulos E, Pantzaki A, Memmos D, Ivens K, Heering PJ. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series. Am J Kidney Dis. 2010;55(2):259-68.
-
(2010)
Am J Kidney Dis
, vol.55
, Issue.2
, pp. 259-268
-
-
Bantis, C.1
Stangou, M.2
Schlaugat, C.3
Alexopoulos, E.4
Pantzaki, A.5
Memmos, D.6
Ivens, K.7
Heering, P.J.8
-
10
-
-
0036045191
-
Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria
-
DOI 10.1023/A:1014424723466
-
Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol. 2002;33:167-71. (Pubitemid 34575432)
-
(2001)
International Urology and Nephrology
, vol.33
, Issue.1
, pp. 167-171
-
-
Harmankaya, O.1
Ozturk, Y.2
Basturk, T.3
Obek, A.4
Kilicarslan, I.5
-
11
-
-
33751404292
-
Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial
-
Japanese Pediatric IgA Nephropathy Treatment Study Group
-
Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006;1:511-7.
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 511-517
-
-
Yoshikawa, N.1
Honda, M.2
Iijima, K.3
Awazu, M.4
Hattori, S.5
Nakanishi, K.6
Ito, H.7
-
12
-
-
77957860383
-
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy
-
Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, Procaccini AD, Locatelli F. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol. 2010;21:1783-90.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 1783-1790
-
-
Pozzi, C.1
Andrulli, S.2
Pani, A.3
Scaini, P.4
Del Vecchio, L.5
Fogazzi, G.6
Vogt, B.7
De Cristofaro, V.8
Allegri, L.9
Cirami, L.10
Procaccini, A.D.11
Locatelli, F.12
-
13
-
-
33751419293
-
IgA nephritis: ACE inhibitors, steroids, both or neither?
-
Locatelli F, Pozzi C, Andrulli S. IgA nephritis: ACE inhibitors, steroids, both or neither? Nephrol Dial Transplant. 2006;21: 3357-61.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 3357-3361
-
-
Locatelli, F.1
Pozzi, C.2
Andrulli, S.3
-
14
-
-
0038512403
-
Treatment of IgA nephropathy with ace inhibitors: A randomized and controlled trial
-
DOI 10.1097/01.ASN.0000068460.37369.DC
-
Praga M, Gutiérrez E, González E, Morales E, Hernández E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol. 2003;14:1578-83. (Pubitemid 36687059)
-
(2003)
Journal of the American Society of Nephrology
, vol.14
, Issue.6
, pp. 1578-1583
-
-
Praga, M.1
Gutierrez, E.2
Gonzalez, E.3
Morales, E.4
Hernandez, E.5
-
15
-
-
0030031995
-
Vasoactive hormones and renal sclerosis
-
Egido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996;49:578-97. (Pubitemid 26051838)
-
(1996)
Kidney International
, vol.49
, Issue.2
, pp. 578-597
-
-
Egido, J.1
-
16
-
-
4444346216
-
Treatment of severe IgA nephropathy with omega-3 fatty acids: The effect of a "very low dose" regimen
-
Alexopoulos E, Stangou M, Pantzaki A, Kirmizis D, Memmos D. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a "very low dose" regimen. Ren Fail. 2004;26:453-9.
-
(2004)
Ren Fail
, vol.26
, pp. 453-459
-
-
Alexopoulos, E.1
Stangou, M.2
Pantzaki, A.3
Kirmizis, D.4
Memmos, D.5
-
17
-
-
12344284903
-
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
-
DOI 10.1111/j.1523-1755.2005.67107.x
-
Novak J, Tomana M, Matousovic K, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005;67:504-13. (Pubitemid 40139842)
-
(2005)
Kidney International
, vol.67
, Issue.2
, pp. 504-513
-
-
Novak, J.1
Tomana, M.2
Matousovic, K.3
Brown, R.4
Hall, S.5
Novak, L.6
Julian, B.A.7
Wyatt, R.J.8
Mestecky, J.9
-
18
-
-
0028137068
-
Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
-
Goumenos DS, Brown CB, Shortland J, el Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant. 1994;9:1418-25.
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 1418-1425
-
-
Goumenos, D.S.1
Brown, C.B.2
Shortland, J.3
El Nahas, A.M.4
-
19
-
-
69449092837
-
Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy
-
Stangou M, Alexopoulos E, Papagianni A, et al. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology. 2009;14:613-20.
-
(2009)
Nephrology
, vol.14
, pp. 613-620
-
-
Stangou, M.1
Alexopoulos, E.2
Papagianni, A.3
-
20
-
-
51649113133
-
C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy
-
Stangou M, Alexopoulos E, Pantzaki A, Leonstini M, Memmos D. C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scand J Urol Nephrol. 2008;42:373-80.
-
(2008)
Scand J Urol Nephrol
, vol.42
, pp. 373-380
-
-
Stangou, M.1
Alexopoulos, E.2
Pantzaki, A.3
Leonstini, M.4
Memmos, D.5
-
22
-
-
0038352217
-
Prednisolone and azathioprine in IgA nephropathy: A ten-year follow-up study
-
Goumenos DS, Davlouros P, El Nahas AM, et al. Prednisolone and azathioprine in IgA nephropathy: a ten-year follow-up study. Nephron Clin Pract. 2003;93:58-68.
-
(2003)
Nephron Clin Pract
, vol.93
, pp. 58-68
-
-
Goumenos, D.S.1
Davlouros, P.2
El Nahas, A.M.3
-
23
-
-
2342576237
-
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
-
DOI 10.1111/j.1523-1755.2004.00588.x
-
Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int. 2004;65:1842-9. (Pubitemid 38591034)
-
(2004)
Kidney International
, vol.65
, Issue.5
, pp. 1842-1849
-
-
Maes, B.D.1
Oyen, R.2
Claes, K.3
Evenepoel, P.4
Kuypers, D.5
Vanwalleghem, J.6
Van Damme, B.7
Vanrenterghem, Y.F.C.8
-
24
-
-
26944490400
-
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy
-
DOI 10.1111/j.1523-1755.2005.00460.x, PII 4494652
-
Tang S, Leung JC, Chan LY, et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int. 2005;68:802-12. (Pubitemid 43323137)
-
(2005)
Kidney International
, vol.68
, Issue.2
, pp. 802-812
-
-
Tang, S.1
Leung, J.C.K.2
Chan, L.Y.Y.3
Lui, Y.H.4
Tang, C.S.O.5
Kan, C.H.6
Ho, Y.W.7
Lai, K.N.8
-
25
-
-
77949542202
-
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
-
Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int. 2010;77(6):543-9.
-
(2010)
Kidney Int
, vol.77
, Issue.6
, pp. 543-549
-
-
Tang, S.C.1
Tang, A.W.2
Wong, S.S.3
Leung, J.C.4
Ho, Y.W.5
Lai, K.N.6
-
26
-
-
27144475414
-
Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double-blind randomized controlled trial
-
DOI 10.1093/ndt/gfh974
-
Frisch G, Lin J, Rosenstock J, et al. Mycophenolate mofetil (MMF) vs. placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant. 2005;20:2139-45. (Pubitemid 41510089)
-
(2005)
Nephrology Dialysis Transplantation
, vol.20
, Issue.10
, pp. 2139-2145
-
-
Frisch, G.1
Lin, J.2
Rosenstock, J.3
Markowitz, G.4
D'Agati, V.5
Radhakrishnan, J.6
Preddie, D.7
Crew, J.8
Valeri, A.9
Appel, G.B.10
-
27
-
-
0037172742
-
A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy
-
Chen X, Chen P, Cai G, et al. A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi. 2002;82:796-801.
-
(2002)
Zhonghua Yi Xue Za Zhi
, vol.82
, pp. 796-801
-
-
Chen, X.1
Chen, P.2
Cai, G.3
|